FibroScan®
Search results for “”
Article
18.04.2024
Revolutionizing Liver Disease Treatment: A Conversation with Dr. Naim Alkhouri about the First-ever Therapeutic for MASH
Article
15.04.2024
Join us on World Liver Day 2024
page
WHO Guidelines on CHB infection - 2024
Press Release
27.03.2024
Welcome Prof. Victor de Lédinghen MD PhD, Our New Chief Medical Officer at Echosens
Podcast
25.03.2024
Beyond Biopsies: The Revolution of Liver Health with FibroScan®
page
Liver Health Super Shaper Award
Webinar
18.03.2024
Using VCTE™ on Patients with Fatty Liver in the Endocrinology Setting
Article
09.10.2023
Turning Point report recommends using FibroScan®
page
Search
Webinar
04.09.2023
Empowering Care in Bariatric and Metabolic Surgery
Article
04.09.2023
Understanding the Nomenclature Shift in Fatty Liver Disease
Webinar
12.06.2023
Diagnosis and Management of MAFLD Patients
Article
07.06.2023
NICE Issues Landmark Guidance to Bring Routine Liver Scans to Primary Care Settings
Article
24.05.2023
Symposium at ILC 2023 with Novo Nordisk
Article
01.05.2023
Hepatitis Awareness Month
Webinar
26.04.2023
Understanding the Role of Elastography for Management of Pediatric Liver Disease
Article
18.04.2023
Liver Health Experts and Echosens Technology Featured on eHealth Radio Network
Press Release
23.03.2023
FDA Expands Indications for Use of FibroScan® for Comprehensive Liver Management
Webinar
16.03.2023
Leveraging FibroScan® Solutions in Clinical Trials
Webinar
10.03.2023
FibroScan® Included in Key International Guidelines
Article
01.03.2023
March is the American National Nutrition Month
page
AASLD Practice Guidance - 2023 update
Webinar
15.02.2023
NASH Club 2023, a series of 3 educational CME accredited HCPs program
Press Release
13.02.2023
New AASLD Practice Guidance Calls for the Use of Noninvasive Liver Evaluations for Earlier Detection of NAFLD and NASH
page
Do you need a liver examination?
page
Test your eligibility for FibroScan® GO
page
Trademarks
Article
18.01.2023
We are shaping the future of liver health- Laurent Sandrin on CNEWS
page
Environmental, Social and Governance
Article
02.11.2022
Addressing Link Between Obesity and Non-Alcoholic Fatty Liver Disease: New SmartExam Technology Extends Use of FibroScan® Among Severely Obese Patients
Webinar
02.11.2022
Understanding New FibroScan® Software Enhancements Which Optimize Overweight Patient Testing
page
White Paper - The Role of FibroScan and Associated Solutions in MASH Clinical Trials
Article
18.10.2022
Echosens Urges Increased Screening, Detection and Monitoring of Liver Health during October Liver Cancer Awareness Month
page
International Guidelines
Webinar
21.09.2022
Examination with FibroScan®: Why do it in Primary Care?
Article
17.08.2022
Upcoming National Health Center Week Showcases Leaders in Preventative Medicine and Early Detection
products
FibroView™ Report
Article
26.07.2022
Halting Hepatitis: One of the World's Major Public Health Crises
Webinar
01.07.2022
FibroScan® Solutions Bringing New Guidelines to Life
Press Release
23.06.2022
Echosens and Novo Nordisk Announce Partnership to Increase Awareness and Advance Early Diagnosis of NASH
Article
22.06.2022
Rate of Body Mass Index Increase Doubled Among Pediatric Patients During COVID-19 Pandemic
Webinar
15.06.2022
NIT-Based NAFLD Identification –Understanding the New AGA Clinical Care Pathway
page
AACE Clinical Practice Guidelines 2022 AASLD
Article
31.05.2022
June 2022 is Liver Health Matters Month
Webinar
24.05.2022
Improving Management of Patients with Advanced Liver Disease Through Liver and Spleen Stiffness Assessment
Article
19.04.2022
World Liver Day - April 19th 2022
Article
04.04.2022
April is the American Alcohol Awareness Month
Article
01.04.2022
April is the American Minority Health Month
Webinar
22.03.2022
Current Perspectives in NAFLD-NASH Identification & Management – A Diabetologist’s Perspective
Article
21.03.2022
American National Drug and Alcohol Facts Week: Raising Awareness About the Link Between Alcohol and Liver Disease
products
FibroScan® GO
Article
10.02.2022
New Baveno VII Guidelines Further Validate FibroScan® for Management of Patients with Advanced Chronic Liver Disease
page
Baveno VII Renewing Consensus - Update 2021
Article
01.02.2022
American Heart Month: Battling the Epidemics of Cardiovascular Disease and Liver Disease
Press Release
15.12.2021
Innovative New Products and Technology Advancing Worldwide Liver Disease Management Highlight Echosens 20th Anniversary
Webinar
24.11.2021
AASLD Wrap Up; Key Lessons in NAFLD NASH Diagnostic Strategies
Article
24.11.2021
Highlights from 2021 AASLD Liver Meeting: Early Detection and Monitoring with FibroScan® Mitigates Risk of Patients Developing Fibrosis/Cirrhosis
Article
02.11.2021
Non-Invasive Point-of-Care Exam Helps Battle Liver Disease in Individuals with Obesity
White Paper
27.10.2021
Independent Study Shows FibroScan® Technology Offers Payers Positive Return on Investment
page
White Paper: Using FibroScan® Technology Offers Payers Cost Savings
Article
01.10.2021
Link Between Non-alcoholic Fatty Liver Disease, Obesity and Liver Cancer Calls for Early Detection and Monitoring
White Paper
14.09.2021
Impact of Obesity in Nonalcoholic Fatty Liver Disease & Metabolic Syndrome
page
White Paper: Diet Metabolic Syndrome
Article
12.08.2021
New EASL Clinical Practice Guidelines Make Unprecedented Recommendation for Non-Invasive FibroScan® and Care Management
Press Release
09.08.2021
Echosens Highlights New EASL Clinical Practice Guidelines
Article
03.08.2021
Douglas Dieterich, M.D., discusses role of FibroScan® in the diagnoses of chronic liver disease
Article
28.07.2021
Non-Invasive Liver Exam Identifies Asymptomatic Liver Disease, Provides Follow-Up for Hepatitis C Virus
Article
26.07.2021
NICE Experts Endorse FibroScan®: Cost-Effective Liver Exam
Article
26.07.2021
Lancet Study: FibroScan® Identifies Severe Fibrosis/Cirrhosis for Earlier Diagnosis
Article
23.07.2021
Population-Based Return on Investment of Deploying Transient Elastography
Article
09.07.2021
Echosens CEO Discusses How Company Helps Fight Liver Disease Epidemic
Webinar
05.07.2021
Enhancing the management of NAFLD patients with FibroScan®-based scores
page
EASL Clinical Practice Guidelines – 2021 update
Press Release
24.06.2021
Leading Liver Disease Researchers Present at EASL International Liver Congress™ 2021
Article
21.06.2021
Celebrating 2 decades of liver health
page
Contact Support
Press Release
09.06.2021
Echosens Launches New FibroScan®-based Scores Agile 3+ & Agile 4
Article
31.05.2021
Help Support First Annual Liver Health Matters Month!
Article
27.05.2021
Research Featured as Cover Story in April Issue of Clinical Gastroenterology & Hepatology Demonstrates FibroScan®’s Ability to Monitor Liver-related Events and Survival
Article
Webinar
26.05.2021
GI Practice Profitability Enhanced by Addition of Obesity & Fatty Liver Chronic Care Management Services
Article
12.05.2021
Dr. Stephen Harrison Discusses Clinical Importance of FibroScan® Technology
products
Agile 4
products
Agile 3+
Article
22.04.2021
FibroScan® 630 Expert: Complete, Non-invasive Solution Offers Effective Management and Risk Stratification for Patients with Cirrhosis and Portal Hypertension
Webinar
10.04.2021
Strategies For Identification of NAFLD NASH in T2DM Using Non Invasive Diagnostic Tools
Article
10.04.2021
Type 2 diabetes: search for « fatty liver »
Article
10.04.2021
Interest of a liver exploration for an early diagnosis of NASH
Article
10.04.2021
FibroScan® and the role of liver stiffness
Article
10.04.2021
VCTE™& elastography
Webinar
10.04.2021
Spleen Stiffness - The Noninvasive Alternative For Assessment of Portal Hypertension & Esophageal Varices Risk
Article
09.04.2021
COVID-19 Impact: Higher Risks of Severity Among Obese and Chronic Liver Disease Patients
Article
09.04.2021
FibroScan® Recommended for Hepatitis C Patients
Article
09.04.2021
Echosens Observes National Drug and Alcohol Facts Week 2021
Article
09.04.2021
Economic Analysis Model Suggests Screening People for Fibrosis With Non-Invasive Tests Cost-effective
Press Release
09.04.2021
International NASH Day 2020
Article
09.04.2021
Innovative FAST™ Score Helps Clinicians Address the Epidemic of Active Fibrotic NASH
Article
09.04.2021
Echosens Takes a Proactive Leadership Position
Article
09.04.2021
HCV Treatments Can Cure Viral Infection, Not Neccessarily Liver Disease
Article
09.04.2021
Answering the worldwide need for chronic liver disease assessment and diagnosis
White Paper
09.04.2021
Looming Epidemic: Non-Alcoholic Fatty Liver Disease
Press Release
09.04.2021
Echosens Appoints Dominique Legros as Group CEO
White Paper
09.04.2021
Fatty Liver in Hepatitis C Patients
Press Release
09.04.2021
Echosens & NASHNet Recognize International NASH Day
Article
09.04.2021
Follow-up of cirrhotic patients after etiologic treatment
Webinar
09.04.2021
Understanding the Place of Non-Invasive Testing in the Management of Chronic Hepatitis C
Webinar
09.04.2021
AASLD 2020 Update
Webinar
09.04.2021
Place of FibroScan® in the management of patients with alcohol use disorders
Webinar
09.04.2021
FibroScan® and Fast™ score: Game Changers in Staging NAFLD and Assessing Treatment Response
Webinar
09.04.2021
2020 EASL UPDATE
Webinar
09.04.2021
Obesity and Fatty Liver Disease: Twin Epidemics
Press Release
09.04.2021
Echosens and NASHNET recognize International NASH DAY
Press Release
09.04.2021
NICE issues briefing on FibroScan® liver exam
Press Release
09.04.2021
World Diabetes Day 2020
page
Bibliography
products
SmartExam
products
FibroScan® Mini 430
page
interview Stephen Harrison
page
interview Frias
page
interview Douglas Dieterich
page
interview Stephen Esposito
page
Probe and machine disinfection
page
Laurent’s story
page
HCV HBV
page
Alcoholic liver disease
page
Patents
page
Clinical Trials
page
Services
page
Clinical Evidences - Archive
page
Clinical Library
products
myFibroScan
products
Fast™
products
FibroScan® Probes
products
FibroScan® Gateway
products
CAP™ module
products
FibroScan® Mini+ 430
products
FibroScan® Compact 530
products
FibroScan® Expert 630
page
Blog and news
page
Privacy notice
page
Legal notice
page
Contact
page
General Terms and Conditions of Sale
page
Covid FAQs
page
Users testimonials
page
Recommendations
page
Locate us
page
Spontaneous application form
page
Working at Echosens
page
Find a FibroScan® near you
page
Information for patients
page
MASLD / MASH
page
Clinical Evidences
page
About us
page
Users
page
Liver health
page
Scores by echosens
page
FibroScan® by echosens
page
Home